Spranger et al. reported that in their melanoma model, tumor intrinsic β-catenin signaling leads to decreased CCL4 production by tumor cells and impaired recruitment of CCR5-expressing cDC1s into the tumor, ultimately resulting in a failure to prime anti-tumor CD8 T cell responses (132). This evidence concerns the gene CCL4 and neoplasm.